The kinetics and magnitude of the synergistic activation of the serum amyloid a promoter by IL-1β and IL-6 is determined by the order of cytokine addition

Scandinavian Journal of Immunology

Volumn 49, Issue 4, 1999, Pages 399-404

  Uhlar, C M ^a   Whitehead, A S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; SERUM AMYLOID A;

ACUTE PHASE RESPONSE; ARTICLE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; PRIORITY JOURNAL; PROMOTER REGION;

DRUG COMBINATIONS; DRUG SYNERGISM; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; KINETICS; PROMOTER REGIONS (GENETICS); SERUM AMYLOID A PROTEIN; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0033009313     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00515.x     Document Type: Article

References (29)

1. Fey GH, Gauldie J. The acute phase response of the liver in inflammation. In: Popper H, Schaffner F, eds. Progress in Liver Diseases, Vol 9. Philadelphia, PA: W. B. Saunders, 1989:89.
2. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15:81-8.
3. Marhaug G. Three assays for the characterization and quantitation of human serum amyloid A. Scand J Immunol 1983;18:329-38.
4. Uhlar CM, Grehan S, Steel DM, Steinkasserer A, Whitehead AS. Use of the acute phase serum amyloid A (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators: Differential kinetics of SAA2 promoter induction by IL-1β and TNFα compared to 1L-6. J Immunol Methods 1997;203;123-30.
5. Steel DM, Whitehead AS. Heterogeneous modulation of acute phase reactant mRNA levels by interleukin-1β and interleukin-6 in the human hepatoma cell line PLC/PRF/5. Biochem J 1991;277:477-82.
6. Steel DM, Donoghue CF, O'Neill RM, Uhlar CM, Whitehead AS. Expression and regulation of constitutive and acute phase serum amyloid A mRNAs in hepatic and non-hepatic cell lines. Scand J Immunol 1996;44:493-500.
7. Betts JC, Cheshire JK, Akira S, Kishimoto T, Woo P. The role of NF-κB and NF-IL-6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J Biol Chem 1993;268:25624-31.
8. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74-8.
9. Utsunomiya I, Nagai S, Oh-Ishi S. Sequential appearance of IL-1 and IL-6 activities in rat carrageenin-induced pleurisy. J Immunol 1991;147:1803-9.
10. Jarvis JN, Wang WL, Moore HT, Zhao L, Xu C. In vitro induction of proinflammatory cylokine secretion by juvenile rheumatoid arthritis synovial immune complexes. Arthritis Rheum 1997;40:2039-49.
11. Dinarello CA. The biological properties of interleukin-1. Eur Cytokine Networks 1994;5:517-31.
12. Brazel D, Nakanishi S, Oster W. Interleukin-1, characterization of the molecule, functional activity, and clinical implications. Biotech Therapeut 1991;2:241-67.
13. Tilg H, Trehu E., Shapiro L, et al. Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1 alpha infusion in humans. Cytokine 1994;6:215-19.
14. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells. IL-6 suppresses IL-1 and TNF. Blood 1990;75:40-7.
15. Edbrooke MR, Foldi J, Cheshire JK, Li F, Faulkes DJ. Woo P. Constitutive and NF-κB-like proteins in the regulation of the serum amyloid A gene by interleukin-1. Cytokine 1991;3:380-8.
16. Huang JH, Rienhoff HY, Liao WS-L. Regulation of mouse serum amyloid A gene expression in transfected hepatoma cells. Mol Cell Biol 1990;10:3619-25.
17. Li X, Huang JH, Rienhoff HY Jr. Liao WS-L. Two adjacent C/EBP-binding sequences that participate in the cell-specific expression of the mouse serum amyloid A3 gene. Mol Cell Biol 1990;10:6624-31.
18. Li X, Liao WS-L. Expression of rat serum amyloid A1 gene involves both C/EBP-like and NFκB-like transcription factors. J Biol Chem 1991;266:15192-201.
19. Li X, Liao WS-L. Cooperative effects of C/EBP-like and NFκB-like binding sites on rat serum amyloid A1 gene expression in liver cells. Nucleic Acids Res 1992;20:4765-72.
20. Ray BK, Ray A. Functional NF-κB element in rabbit serum amyloid A gene and its role in acute phase induction. Biochem Biophys Res Commun 1993;193:1159-67.
21. Ray A, Ray BK. Serum amyloid A gene expression under acute-phase conditions involves participation of inducible C/EBP-β and C/EBP-γ and their activation by phosphorylation. Mol Cell Biol 1994;14:4324-32.
22. Ray A, Ray BK. Serum amyloid A gene expression level in liver in response to different inflammatory agents is dependent upon the nature of activated transcription factors. DNA Cell Biol 1997;16:1-7.
23. Ray A, Hannink M, Ray BK. Concerted participation of NF-kappa B and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver. J Biol Chem 1995;270:7365-74.
24. Lu S-Y, Rodriguez M, Liao WS-L. YY1 represses rat serum amyloid A1 gene transcription and is antagonized by NF-κB during acute-phase response. Mol Cell Biol 1994;14:6253-63.
25. Ren YS, Reddy S, Huang J, Liao WS-L. Repression of serum amyloid A-1 (SAA1) promoter by transcription factor AP-2. FASEB J 1997;11:A2011.
26. Ray A, Ray BK. A novel cis-acting element is essential for cytokine-mediated transcriptional induction of the serum amyloid A gene in nonhepatic cells. Mol Cell Biol 1996;16:1584-94.
27. Ray BK, Ray A. Involvement of an SAF-like transcription factor in the activation of serum amyloid A gene in monocyte/macrophage cells by lipopolysaccharide. Bioehem J 1996;36:4662-8.
28. Ray BK, Ray A. Induction of serum amyloid A (SAA) gene by SAA-activating sequence-binding factor (SAF) in monocyte/macrophage cells. Evidence for a functional synergy between SAF and Spl. J Biol Chem 1997;272:28948-53.
29. Huang JH, Liao WS-L. Induction of the mouse serum amyloid A3 gene by cytokines requires both C/EBP family proteins and a novel consitutive nuclear factor. Mol Cell Biol 1994;14:4475-84.